Dehydroandrographolide succinate
CAS No. 786593-06-4
Dehydroandrographolide succinate( —— )
Catalog No. M19106 CAS No. 786593-06-4
Dehydroandrographolide Succinate is a traditional Chinese medicine used in the treatment of pneumonia, respiratory tract infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 25MG | 38 | In Stock |
|
| 50MG | 60 | In Stock |
|
| 100MG | 86 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 212 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDehydroandrographolide succinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDehydroandrographolide Succinate is a traditional Chinese medicine used in the treatment of pneumonia, respiratory tract infection.
-
DescriptionDehydroandrographolide Succinate is a traditional Chinese medicine used in the treatment of pneumonia, respiratory tract infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number786593-06-4
-
Formula Weight532.58
-
Molecular FormulaC28H36O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (187.77 mM)
-
SMILESO=C(O)CCC(=O)O[C@@H]3CC[C@@]2(C)[C@H](/C=C/C1=CCOC1=O)C(=C)CC[C@@H]2[C@]3(C)COC(=O)CCC(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(S)-OSMI 3
(S)-OSMI 3 (Ent-OSMI-3) has anti-inflammatory and anti-tumour activity and can be used to study diabetes and neurodegenerative diseases.
-
E-I-L-D-V, human, bo...
EILDV (human, bovine, rat) is an analogue of the active pentapeptide. EILDV (human, bovine, rat) has active tripeptide amino acid sequence LDV that is conserved in human, bovine, rat. EILDV (human, bovine, rat) can be used for the research of cell adhesion.
-
Complanatuside 6-mal...
Complanatuside 6''-malonate
Cart
sales@molnova.com